top of page
GT Logo White.png

2025
Chiesi Air Golden Ticket

the impulse.jpeg
BioLabs_CB_Logo_transparent.png

Chiesi Air through the Impulse is sponsoring a competition to award up to two Golden Tickets at any BioLabs site located in the US. The Impulse is Chiesi’s global initiative dedicated to advancing healthcare through bold, patient-centred innovation. Each Golden Ticket provides one year of fully paid individual bench space and membership at a fully equipped laboratory designed to accelerate  innovative, life-science startups working on research and development of innovative biotechnological solutions that promote tissue repair and/or regeneration in chronic lung diseases such as chronic obstructive pulmonary disease (COPD), asthma, bronchiectasis and idiopathic pulmonary fibrosis (IPF). Additional eligibility requirements are listed below.​

Application

Application Process

The official application process can be found below. Please read and verify your availability before submitting your application. 

calendar.png

Application

Complete the online application form and upload a non-confidential pitch deck for this competition.

laptop.png

Terms & Conditions

Each applicant must acknowledges that they have read the official Terms and Conditions and they fully agrees and accept them. 

handshake.png
Benefits

Golden Ticket Benefits

Eligibility

Eligibility Snapshot

Chiesi Air is looking for biotech companies working on research and development of innovative biotechnological solutions that promote tissue repair and/or regeneration in chronic lung diseases such as chronic obstructive pulmonary disease (COPD), asthma, bronchiectasis and idiopathic pulmonary fibrosis (IPF).  Judging Criteria will include the following: 

  • Innovation and Scientific Merit: Originality and soundness of the proposed approach.

  • Susustainability, Feasibility and Scalability: Potential for translation into clinical practice and scalability for widespread use.

  • Impact: Potential to significantly improve patient outcomes and address current limitations in the field.​

  • Interdisciplinary Collaboration: Integration of expertise across biology, engineering, data science, and clinical research.

  • Applicability of technology for addressing chronic respiratory diseases with demonstrated unmet medical needs.

  • Pre-clinical evidence to support quality and feasibility of the technology.

  • Potential for platform development.

  • Strength of prospective clinical impact and differentiation within the competitive landscape.

  • Capability to clearly define, communicate, and achieve proposed research milestones.

  • Motivation and qualifications of the team supporting the technology.

  • Alignment with Chiesi’s mission in prioritizing sustainability, health equity, and patient care.

  • Must meet BioLabs’ resident criteria.

  • Readiness to move into the BioLabs lab space shortly after receiving an Award (subject to site availability).

For additional requirements refer to the Terms and Conditions

Application Process

The Application Process

01

Submit the online application by September 30th, 2025

02

A subset of applications will be identified as finalist by the contest judges by
October 7th, 2025

03

Virtual final pitch event to select winners on
October 20th, 2025

04

Up to 2 awards will be granted
Good luck!

Contact Us

If you have any questions regarding this competition, contact

theimpulse@chiesi.com

If you have any questions about BioLabs, contact

goldenticket@biolabs.io

 

shutterstock_408838849_edited.jpg
bottom of page